{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:19:32Z","timestamp":1772101172685,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jinf.2012.12.005","type":"journal-article","created":{"date-parts":[[2013,1,5]],"date-time":"2013-01-05T11:45:36Z","timestamp":1357386336000},"page":"381-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Interferon-\u03b3 release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: An evidence-based review"],"prefix":"10.1016","volume":"66","author":[{"given":"Laura","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Santin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"RR-11","key":"10.1016\/j.jinf.2012.12.005_bib1","first-page":"1","article-title":"Essential components of a tuberculosis prevention and control program: recommendations of the Advisory Council for the Elimination of Tuberculosis","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR"},{"key":"10.1016\/j.jinf.2012.12.005_bib2","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1128\/JCM.41.6.2706-2708.2003","article-title":"Molecular and conventional epidemiology of tuberculosis in Hong Kong: a population-based prospective study","volume":"41","author":"Chan-Yeung","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2012.12.005_bib3","first-page":"CD001363","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","volume":"2","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jinf.2012.12.005_bib4","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"1","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jinf.2012.12.005_bib5","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsbourgh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2012.12.005_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2012.12.005_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-gamma release assays and tuberculin skin testing for predicting progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2012.12.005_bib8","first-page":"1235","article-title":"Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada","volume":"12","author":"Hirsch-Moverman","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2012.12.005_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2012.12.005_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of Mycobacterium tuberculosis antigen-specific interferon gamma assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jinf.2012.12.005_bib11","doi-asserted-by":"crossref","first-page":"e000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2012.12.005_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-6-9","article-title":"Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies","volume":"6","author":"Whiting","year":"2006","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jinf.2012.12.005_bib13","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Weich V. The Newcasttle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm. [accessed 16.08.11]."},{"key":"10.1016\/j.jinf.2012.12.005_bib14","unstructured":"World Bank Group. Available at: http:\/\/www.worldbank.org. [accessed 01.12.12]."},{"key":"10.1016\/j.jinf.2012.12.005_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2288-9-80","article-title":"Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data","volume":"9","author":"Wallace","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jinf.2012.12.005_bib16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1378\/chest.11-1158","article-title":"Performance of confirmatory interferon-gamma release assays in school TB outbreaks","volume":"141","author":"Song","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2012.12.005_bib17","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.00098509","article-title":"Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts","volume":"35","author":"Kik","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2012.12.005_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a whole-blood interferon-gamma release assay for developing active tuberculosis: an update","volume":"183","author":"Diel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2012.12.005_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2009.09331.x","article-title":"Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-\u03b3 release assay vs. tuberculin skin test","volume":"161","author":"Laffite","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jinf.2012.12.005_bib20","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1468-3083.2011.04220.x","article-title":"Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study","volume":"26","author":"Garcovich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jinf.2012.12.005_bib21","first-page":"1209","article-title":"Predictive values of QuantiFERON\u00ae-TB Gold testing in screening for tuberculosis disease in asylum seekers","volume":"14","author":"Harstad","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2012.12.005_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-149-11-200812020-00248","article-title":"Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact","volume":"149","author":"Bakir","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2012.12.005_bib23","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s10067-011-1771-9","article-title":"Interferon-gamma release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea","volume":"30","author":"Chang","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jinf.2012.12.005_bib24","doi-asserted-by":"crossref","first-page":"e1379","DOI":"10.1371\/journal.pone.0001379","article-title":"Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux test in Gambian case contacts","volume":"3","author":"Hill","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2012.12.005_bib25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1164\/rccm.200912-1875OC","article-title":"T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease","volume":"182","author":"Leung","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2012.12.005_bib26","doi-asserted-by":"crossref","first-page":"e17984","DOI":"10.1371\/journal.pone.0017984","article-title":"The tuberculin skin test versus QuantiFERON-TB Gold in predicting tuberculosis disease in an adolescent cohort study in South Africa","volume":"6","author":"Mahomed","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2012.12.005_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1183\/09031936.00030610","article-title":"Interferon-gamma release assays in tuberculosis contacts: is there a window period?","volume":"37","author":"Anibarro","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2012.12.005_bib28","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/597351","article-title":"Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals","volume":"48","author":"Aichelburg","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.12.005_bib29","unstructured":"World Health Organization (WHO). Available at: http:\/\/whqlibdoc.who.int\/hq\/2011\/WHO_HTM_TB_2011.17_eng.pdf. [accessed 01.09.11]."}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312003866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312003866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:17:29Z","timestamp":1759007849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445312003866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0163445312003866"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2012.12.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-\u03b3 release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: An evidence-based review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2012.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}